Takeda Pharmaceutical Company Limited (TAK) Net Income by Year
Takeda Pharmaceutical Company Limited reported $720.0M in net income in fiscal year 2025. This represents a decrease of 24.4% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Takeda Pharmaceutical Company Limited has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TAK Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TAK Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Takeda Pharmaceutical Company Limited financials
Frequently Asked Questions
What was Takeda Pharmaceutical Company Limited's net income in fiscal year 2025?
Takeda Pharmaceutical Company Limited reported $720.0M in net income in fiscal year 2025.
How fast is Takeda Pharmaceutical Company Limited's net income growing?
Takeda Pharmaceutical Company Limited (TAK) net income fell by 24.4% year over year, from $952.7M to $720.0M in fiscal year 2025.
How has Takeda Pharmaceutical Company Limited's net income changed over the years?
Across the 9 fiscal years this page covers, Takeda Pharmaceutical Company Limited (TAK) net income went from $1.0B in fiscal year 2017 to $720.0M in fiscal year 2025.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Takeda Pharmaceutical Company Limited (TAK) reported on that line in every period on record.